Haemonetics gets US FDA clearance for enhancements to NexSys PCS plasma collection system

June 24, 2023

Haemonetics Corporation, a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, announced it has received clearance from the?US Food and Drug Administration? (FDA) for advancements to its NexSys PCS plasma collection system. These include a new plasma collection bowl, featuring a patented design that optimizes performance, and new Express Plus Technology engineered to reduce procedure time.


Haemonetics is the leader in the plasma collections market, with five decades of industry experience and over 50 million real-world collections to date on NexSys PCS, the industry's most advanced, completely integrated system designed to streamline plasma collections and improve yield, productivity, safety, quality, compliance, and donor satisfaction. With the latest advancements, Haemonetics expects an average procedure time of 33 to 38 minutes using the standard FDA nomogram, helping customers achieve new levels of plasma center efficiency and lower costs to collect.

The bi-directionally connected NexSys PCS with NexLynk DMS donor management software already delivers a 16-minute reduction in donor door-to-door time, on average, with a significant portion of this improvement occurring pre- and post-procedure. Additionally, NexSys PCS with Persona Technology safely delivers on average a +9% to 12% additional plasma yield by personalizing each collection to the individual donor characteristics. Haemonetics is planning an initial market release of NexSys PCS with the new bowl and Express Plus Technology over the coming months.

"Haemonetics sets the standard in global plasma collection solutions that meet collectors' most critical needs. With our redesigned bowl and new Express Plus Technology for faster procedure times and enhanced plasma center efficiency, we continue to advance our innovation to lead the industry in reducing cost per liter for collectors and ensuring the best experience for their donors," said Roy Galvin, president, global plasma and blood center at Haemonetics.

Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare.

PHARMABIZ.com